Background—Despite rapid clinical translation and widespread enthusiasm, the therapeutic
benefits of adult bone marrow cell (BMC) transplantation in patients with ischemic heart …

Background Cell transplantation offers a potential therapeutic approach to the repair and
regeneration of damaged vascular and cardiac tissue after acute myocardial infarction (AMI) …

Background Cardiovascular magnetic resonance myocardial feature tracking (CMR-FT) is a
recently described method of post processing routine cine acquisitions which aims to …

Randomized, controlled clinical trials have demonstrated that cell therapy can improve the
recovery of cardiac function in patients after acute myocardial infarction (AMI). Trial results …

Aims Previous trials that investigated cell therapy as an adjunctive therapy after acute
myocardial infarction (AMI) have shown conflicting results. We designed a randomized …

Background—Several cell-based therapies for adjunctive treatment of acute myocardial
infarction have been investigated in multiple clinical trials, but the benefits still remain …

Background This comprehensive systematic review and meta-analysis investigated the mid-
to long-term efficacy and safety of stem cell therapy in patients with acute myocardial …

Cardiac cell therapy has now been in clinical use since 10years. Both autologous skeletal
myoblasts and bone marrow-derived different cell subsets (mononuclear cells …

Heart failure commonly results from an irreparable damage due to cardiovascular diseases
(CVDs), the leading cause of morbidity and mortality in the United States. In recent years, the …

The midterm effects of cardiac telocytes (CT s) transplantation on myocardial infarction (MI)
and the cellular mechanisms involved in the beneficial effects of CT s transplantation are not …